P3 Health Partners (NASDAQ:PIII) Sees Unusually-High Trading Volume

Shares of P3 Health Partners Inc. (NASDAQ:PIIIGet Free Report) saw unusually-strong trading volume on Tuesday . Approximately 519,091 shares were traded during mid-day trading, an increase of 14% from the previous session’s volume of 454,236 shares.The stock last traded at $1.65 and had previously closed at $1.68.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. BTIG Research assumed coverage on P3 Health Partners in a report on Thursday, August 31st. They issued a “buy” rating and a $5.00 target price for the company. TD Cowen initiated coverage on shares of P3 Health Partners in a research note on Friday, June 30th. They set a “market perform” rating for the company.

Check Out Our Latest Stock Analysis on P3 Health Partners

P3 Health Partners Stock Performance

The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 16.13. The firm’s fifty day moving average is $2.11 and its 200 day moving average is $2.27.

P3 Health Partners (NASDAQ:PIIIGet Free Report) last announced its earnings results on Monday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.15. P3 Health Partners had a negative return on equity of 2,471.27% and a negative net margin of 10.92%. The business had revenue of $329.09 million during the quarter, compared to analyst estimates of $303.30 million. On average, equities analysts forecast that P3 Health Partners Inc. will post -0.96 EPS for the current year.

Insider Buying and Selling at P3 Health Partners

In other P3 Health Partners news, major shareholder Pacific Founders Ugp I. Chicago bought 90,000 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was acquired at an average cost of $1.83 per share, for a total transaction of $164,700.00. Following the completion of the transaction, the insider now owns 49,305,442 shares in the company, valued at $90,228,958.86. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Insiders have acquired 720,000 shares of company stock valued at $1,427,400 in the last quarter. 17.06% of the stock is owned by insiders.

Hedge Funds Weigh In On P3 Health Partners

A number of institutional investors have recently modified their holdings of PIII. Marietta Investment Partners LLC purchased a new stake in shares of P3 Health Partners in the first quarter valued at approximately $26,000. Squarepoint Ops LLC purchased a new position in P3 Health Partners during the 4th quarter worth $31,000. Walleye Trading LLC bought a new stake in P3 Health Partners during the 2nd quarter valued at $34,000. State Board of Administration of Florida Retirement System purchased a new stake in shares of P3 Health Partners in the 2nd quarter worth $34,000. Finally, SlateStone Wealth LLC bought a new position in shares of P3 Health Partners during the 2nd quarter worth $39,000. 23.57% of the stock is owned by hedge funds and other institutional investors.

P3 Health Partners Company Profile

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

Further Reading

Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.